Kirk Ways

Director/Miembro de la Junta en SPRUCE BIOSCIENCES, INC. .

Fortuna: - $ al 30/04/2024

72 años

Health Technology

Consumer Services

Perfil

Kirk Ways is an Independent Director at Spruce Biosciences, Inc. He previously worked as the Vice Chairman-Department of Internal Medicine at Brody School of Medicine, Development Head-Cardiovascular & Metabolism at Janssen Pharmaceuticals, Inc., and Chief Development Officer & Vice President at BioStratum, Inc. He also served as the Chief Medical Officer at Nuvelution Pharma, Inc. from 2018 to 2021.
Dr. Ways completed his undergraduate degree at Bridgewater College and his doctorate at The University of North Carolina at Chapel Hill.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SPRUCE BIOSCIENCES, INC. -.--%	25/03/2024	0 ( -.--% )	- $	30/04/2024

Cargos activos de Kirk Ways

Empresas	Cargo	Inicio
SPRUCE BIOSCIENCES, INC.	Director/Miembro de la Junta	23/06/2021

Todos los cargos activos de Kirk Ways

Antiguos cargos conocidos de Kirk Ways.

Empresas	Cargo	Fin
Nuvelution Pharma, Inc. Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA.	Director Técnico/Científico/I+D	01/01/2021
BioStratum, Inc. BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC.	Corporate Officer/Principal	05/07/2011
Brody School of Medicine	Corporate Officer/Principal	-
Janssen Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Kirk Ways.

Formación de Kirk Ways.

The University of North Carolina at Chapel Hill	Doctorate Degree
Bridgewater College	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kirk Ways.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SPRUCE BIOSCIENCES, INC.	Health Technology

Empresas privadas	3
BioStratum, Inc. BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC.	Health Technology
Nuvelution Pharma, Inc. Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA.	Health Technology
Janssen Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.	Health Technology

Ver las conexiones de la empresa